CannTrust Holdings Inc. (CTST)
(Delayed Data from NYSE)
$6.05 USD
+0.46 (8.23%)
Updated May 3, 2019 04:02 PM ET
After-Market: $6.08 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.05 USD
+0.46 (8.23%)
Updated May 3, 2019 04:02 PM ET
After-Market: $6.08 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
CannTrust Holdings (CTST) in Focus: Stock Moves 6.1% Higher
by Zacks Equity Research
CannTrust Holdings (CTST) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Kamada (KMDA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Kamada (KMDA) is expected to provide updates on pipeline candidates during the first-quarter earnings call.
Dr. Reddy's (RDY) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Dr. Reddy's (RDY) will provide updates on new generic filings and new drug applications, when it reports fourth-quarter fiscal 2019 results.
What's in Store for Affimed (AFMD) This Earnings Season?
by Zacks Equity Research
Affimed (AFMD) is likely to provide update on the progress of its pipeline candidates when its reports first-quarter results.
3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates
by Zacks Equity Research
So far this earnings season, the going seems to be good for the medical sector. Let us take a glance at a few small drug companies, which are likely to beat on Q1 earnings.
Implied Volatility Surging for CannTrust (CTST) Stock Options
by Zacks Equity Research
Investors need to pay close attention to CannTrust (CTST) stock based on the movements in the options market lately.